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Abscisic acid (ABA) controls many physiological
processes and mediates adaptive responses to
abiotic stresses. The ABA signaling mechanisms for
abscisic acid receptors PYR/PYL/RCAR (PYLs)
were reported. However, it remains unclear whether
the molecular mechanisms are suitable for other
PYLs. Here, complex structures of PYL3 with
(+)-ABA, pyrabactin andHAB1 are reported. An unex-
pected trans-homodimer intermediate observed in
the crystal is confirmed in solution. ABA-bound
PYL3 greatly promotes the generation of monomeric
PYL3, which can excessively increase the efficiency
of inhibiting PP2Cs. Structure-guided biochemical
experiments show that Ser195 accounts for the key
intermediate. Interestingly, pyrabactin binds to
PYL3 in a distinct nonproductive mode with gate
closure, which sheds light on the design of agonists
and antagonists for abscisic acid receptors. Accord-
ing to different conformations of ligand-bound
PYLs, the PYLs family can be divided into three
subclasses, among which the trans-dimeric sub-
class, represented by PYL3, reveals a distinct regula-
tory mechanism.
INTRODUCTION
The phytohormone abscisic acid (ABA) is vital for the regulation
of many processes such as plant growth, stomatal aperture,
seed maturation, dormancy, and response to abiotic stresses
including drought, cold, and salinity (Cutler et al., 2010; Finkel-
stein et al., 2002; Raghavendra et al., 2010). Plant ABA content
significantly increases under abiotic stresses, which changes
the expression of related genes and chemical substances and
allows the plant to adapt to stress conditions. Therefore, under-
standing the events in ABA signal transduction has been one of
the most important goals in plant research.
The recent identification of the pyrabactin (4-bromo-N-
pyridin-2-yl methyl naphthalene-1-sulfonamide) resistance780 Structure 20, 780–790, May 9, 2012 ª2012 Elsevier Ltd All rights(PYR/PYL)/regulatory component of ABA receptor (RCAR) family
(hereafter referred to as PYLs) and their biochemical modes of
action represent a major breakthrough in the field (Ma et al.,
2009; Park et al., 2009). The structures of apo- and ABA-bound
abscisic acid receptors PYL1, PYL2, and PYR1 were solved by
several groups (Melcher et al., 2009; Miyazono et al., 2009;
Nishimura et al., 2009; Santiago et al., 2009; Yin et al., 2009).
Based on these structures, an ABA signaling mechanism was
proposed. In these structures, PYL1, PYL2, and PYR1 are cis-
homodimers. This term is used to describe two PYL molecules
that bind to each other in the same direction (i.e., in a parallel
binding mode). Upon binding to ABA or pyrabactin, the gate
(Melcher et al., 2009) of PYL undergoes a pronounced conforma-
tional change, and the PYL protomers in the cis-homodimer
separate slightly, decreasing the area of interface and creating
a binding surface for protein phosphatase 2C (PP2C). Upon
binding to PP2C, ligand-bound PYL dimers disassociate and
form a PYL/PP2C heterodimer via the newly formed surface. In
the absence of ABA, the kinase activity of SnRK2 is abrogated
by PP2Cs through physical interaction and dephosphorylation
(Soon et al., 2012). Therefore, the heterodimer PYL/PP2C
occludes the catalytic site of PP2Cs and releases PP2C-medi-
ated inhibition of proteins such as SnRK2 (Fujii et al., 2009).
The PYL family (Lytle et al., 2009) contains 14 high-similarity
members in Arabidopsis thaliana. It is unclear whether this
molecular mechanism is applicable to other abscisic acid
receptors. In addition, it is controversial whether apo-PYLs and
ABA-bound PYLs exist as a monomer or dimer in solution. Gel
filtration coupled to multi-angle laser light scattering and small
angle X-ray scattering analysis (SAXS) showed that both PYR1
and PYL2 are dimers either in the presence or in the absence
of ABA (Nishimura et al., 2009; Santiago et al., 2009; Yin et al.,
2009). However, apo-PYL2 was determined to be monomer in
solution by gel filtration and NMR, whereas apo-PYL1was deter-
mined to exist in a monomer–dimer equilibrium in solution
(Melcher et al., 2009). Moreover, one important question is
whether an intermediate can be detected during the mono-
mer–dimer equilibrium if the monomer exists.
In vivo, the Arabidopsis triple (pyr1;pyl1;pyl4) and quadruple
(pyr1;pyl1;pyl2;pyl4) mutants are less sensitive to (+)-ABA
inhibition in seed germination and root growth compared to
wild-type (Park et al., 2009). However, the quadruple mutant
still responded to ABA signals, such as the expression of RD29reserved
Figure 1. Formation of the PYL3 trans-Dimers with
the Addition of Two Ligands
(A) Apo-PYL3 cis-homodimer, two protomers are related
by a 2-fold rotation axis, parallel to the plane of the page.
(B) Superposition of (+)-ABA-bound PYL3 trans-homo-
dimer (green) with apo-PYL3 cis-homodimer (purple) in Ca
trace mode. (+)-ABA is labeled in blue.
(C) The stereo view of the PYL3-(+)-ABA complex struc-
ture. The ABA (color blue) binding pocket in ligand-bound
PYL3 is exposed to the solvent and cycled (magenta). Two
protomers are related by a 2-fold rotation axis, perpen-
dicular to the plane of the page.
See also Figures S1, S2, and S3 and Table S1.
Structure
Structures and Unique Mechanism of ABA Receptor PYL3in the presence of (+)-ABA. These data imply that other important
abscisic acid receptors are required for ABA signaling. Accord-
ing to the data mining from the Arabidopsis expression data,
PYR1, PYL1, PYL2, and PYL4 were almost not expressed during
seed development (Winter et al., 2007) (Figure S1 available
online). On the contrary, PYL3/RCAR13 is primarily expressed
in the chalazal seed coat during seed development, especially
in the globular stage (Figure S1). In plant ovules, the chalazal is
an important tissue in the testa where the connection of the
vascular tissues of the maternal funiculus to the seed ends. It
is involved in transferring nutrient resources from the mother
plant. During early seed development in Arabidopsis, ABA
content of seed fluctuates greatly and increases to a maximum
between one-third to one-half of the time from seed initiation
to maturity (Karssen et al., 1983). Interestingly, ABA was prefer-
entially detected in the nucellus near the chalaza (Peng et al.,
2006), and was found to be related to assimilate flow and distri-
bution. In developing seeds, ABA is necessary for inducing the
synthesis of reserve proteins and lipids (Finkelstein et al.,
2002), as well as for seed physiological dormancy and the desic-
cation tolerance, to prevent premature germination at the end of
the cell division phase of embryogenesis. Considering that PYL3
is highly expressed in the chalazal seed coat from microarray
studies, it is speculated to be involved in the complex regulation
of ABA signaling pathway, such as assimilates and signal
transduction.
The complex structures of PYL1, PYL2, and PYR1 with pyra-
bactin were also reported (Hao et al., 2010; Melcher et al.,
2010; Peterson et al., 2010; Yuan et al., 2010). Pyrabactin
bound to PYL1 or PYR1 in productive mode as an agonist
whereas to PYL2 in nonproductive mode as an antagonist.
Whether the closed state of the gate responding to pyrabactin
is an exclusive determinant of agonists/antagonists for abscisic
acid receptors (Hao et al., 2010; Melcher et al., 2010; Peterson
et al., 2010; Yuan et al., 2010) remains to be elucidated. In addi-Structure 20, 780–790, May 9tion, microarray analyses have revealed that
the transcriptional responses induced by pyra-
bactin, a synthetic seed germination inhibitor
of ABA, are highly correlated with ABA
responses in seeds (Park et al., 2009). Although
the complex structures of PYR1, PYL1, or
PYL2 with pyrabactin were solved recently
(Hao et al., 2010; Melcher et al., 2010; Peterson
et al., 2010; Yuan et al., 2010), the mechanismunderlying that pyrabactin inhibits seed development is not
clear.
To explore the aforementioned issues, we focused on the
structure–function relationship of PYL3, the most abundantly
expressed PYL during seed development. Based on a combina-
tion of structural and biochemical methods, high-resolution
crystal structures of apo-PYL3 and its structures in complex
with (+)-ABA, pyrabactin and HAB1 were determined, respec-
tively. Upon ligand binding, the apo-PYL3 cis-homodimer is
converted to a trans-homodimer, in which two ligand-bound
PYLs bind to each other in a reverse direction. To our knowledge,
this represents a novel intermediate found naturally in the
dissociation of PYLs. Meanwhile, Ser195 in PYL3 accounts for
the generation of the key intermediates in the presence of
ligands. Interestingly, pyrabactin as an antagonist binds to
PYL3 with gate closure, which sheds light on the design of
agonists and antagonists. According to conformations of
ligand-bound PYLs, the PYR/PYL/RCAR family can be divided
into three subclasses, which represent different mechanisms
of themselves.
RESULTS
PYL3-Ligand Complexes in Crystal
Are trans-Homodimers
Recently, it was shown that the ability of PYL3 in the reconstitu-
tion of the ABA signaling pathway for SnRK2-mediated phos-
phorylation in vitro was lowest among PYLs protein (Fujii et al.,
2009). To understand the molecular mechanism underlying the
functions of PYL3 distinct from other PYLs, we obtained crystal
structures of apo-PYL3 and (+)-ABA bound PYL3. The apo-PYL3
structure was solved by heavy atom Pt soaking by SIRAS. There
are two PYL3 protomers in the asymmetric unit (Figure 1A and
Table 1). One PYL3 protomer consists of four a helices and
seven b sheets (Figure S2). It shares a number of unique, 2012 ª2012 Elsevier Ltd All rights reserved 781
Table 1. Data Collection and Refinement Statistics of PYLs and Complexes
Data Collection PYL2 PYL3 + Pt PYL3 PYL3 + (+)- ABA PYL3 + (+)- ABA
PYL3
Pyrabactin
PYL3 + ABA +
HAB1
Space group P3121 P41212 P41212 I 2121 21 R32 P212121 P 21
Cell dimensions (A˚)
a 61.14 86.79 86.96 63.19 232.84 53.63 39.75
b 61.14 86.79 86.96 89.04 232.84 67.53 69.72
c 184.77 154.30 154.12 206.69 53.29 109.08 82.89
a 90 90 90 90 90 90 90
b 90 90 90 90 90 90 101.6
g 120 90 90 90 120 90 90
Resolution range (A˚)a 50-1.55
(1.58–1.55)
50-2.75
(2.80–2.75)
50-2.50
(2.54–2.50)
40-2.70
(2.77–2.70)
50-1.95
(1.98–1.95)
50-1.83
(1.86–1.83)
50-2.21
(2.25–2.21)
Rmerge (%) 5.6 (66.7) 5.6 (98.4) 6.5 (87.4) 7.7 (59.1) 9.6 (46.9) 8.7 (52.9) 9.6 (33.0)
I/sI 60.2 (3.4) 69.1 (3.2) 75.9 (2.6) 26.5 (2.27) 21.8 (2.70) 29.7 (3.0) 14.2 (3.0)
Completeness (%) 98.7 (98.6) 99.6 (100.0) 99.3 (100.0) 93.0 (86.1) 99.8 (99.4) 98.4 (68.1) 91.3 (80.1)
Redundancy 10.6 (9.8) 18.2 (19.0) 13.4 (9.0) 3.8 (3.8) 5.8 (4.5) 12.8 (5.4) 4.8 (3.7)
Refinement
Resolution (A˚) 20-1.55
(1.58–1.55)
20-2.50
(2.56–2.50)
40-2.70
(2.77–2.70)
50-1.95
(2.00–1.95)
50-1.83
(1.86–1.83)
50-2.21
(2.27–2.21)
No. of reflections 56,658 (2,860) 19,933 (1,442) 14,522 (769) 37,987 (1,950) 32,704 (1,731) 19,318 (1,012)
Rwork/Rfree (%) 20.1/22.4
(25.7/28.0)
25.2/27.0
(59.6/67.5)
24.8/28.1
(44.1/51.1)
19.8/22.1
(24.6/26.7)
19.7/21.6
(33.4/34.7)
18.6/22.1
(21.4/29.4)
No. of atoms
Protein 2,781 2,749 2,491 2,678 2,910 3,555
Ligand/ion 0 10 38 40 54 32
Water 241 124 167 690 576 343
B-factors
Protein 25.37 72.97 80.91 28.57 19.80 26.98
Ligand/ion — 113.56 77.23 22.26 23.96 29.19
Water 31.88 44.52 73.20 47.37 36.19 35.96
Rmsd
Bond length (A˚) 0.007 0.008 0.009 0.008 0.007 0.008
Bond angles () 1.493 1.147 1.339 1.074 1.069 1.141
Ramachandran
plot statistics (%)
Residues in most
favored regions
89.2 87.9 84.5 93.4 92.1 92.1
Residues in additional
allowed regions
10.1 11.5 15.5 6.6 7.9 7.9
Residues in generously
allowed regions
0.7 0.6 0.0 0.0 0.0 0.0
Residues in disallowed
regions
0.0 0.0 0.0 0.0 0.0 0.0
Three crystal experiments for each structure.
aStatistics for highest resolution shell.
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Structures and Unique Mechanism of ABA Receptor PYL3conserved residues with other solved PYL family members
(Melcher et al., 2009; Miyazono et al., 2009; Nishimura et al.,
2009; Santiago et al., 2009; Yin et al., 2009). Moreover, the
arrangement of the apo-PYL3 dimer is a cis-homodimer, similar
to the solved structures of PYR1, PYL1, or PYL2. This term is
used to describe two PYL molecules that bind to each other in
the same direction (i.e., in a parallel binding mode).782 Structure 20, 780–790, May 9, 2012 ª2012 Elsevier Ltd All rightsThe complex crystal of PYL3 with (+)-ABA was diffracted to
2.7 A˚ in the space group I212121 and solved by molecular
replacement (Table 1). The complex structure had two PYL3 pro-
tomers in each asymmetric unit (Figure 1C). The protomer struc-
ture in the PYL3-(+)-ABA complex is similar to that of apo-PYL3,
with a root-mean-square deviation (rmsd) of 1.2 A˚ between their
C-a atoms. An electron density appeared in the conservedreserved
Figure 2. Conformation Change of PYL3
Protomer upon the Addition of Two Ligands
and the Dimeric Interface in the trans-
Homodimer
(A) Superposition of two ligand-bound PYL3
protomers with apo-PYL3 (apo-PYL3, yellow;
S-(+)-ABA complex, green; pyrabactin complex,
purple).
(B) Interaction of two PYL3 molecules in PYL3-
(+)-ABA structure (cyan and green). Two hydro-
phobic zones are shown as brown ellipse and two
hydrogen bonds are labeled. Asn180 and Asp184
of one protomer are close to Thr209 and Pro208 of
another protomer in the trans-homodimer.
See also Figures S3, S5, and S8.
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Structures and Unique Mechanism of ABA Receptor PYL3pocket of each PYL3 molecule (Figure S3A). This electron
density was solved as the (+)-ABA molecule and the position
(Figure S3C), similar to other PYLs-(+)-ABA complexes (Melcher
et al., 2009; Miyazono et al., 2009; Nishimura et al., 2009;
Santiago et al., 2009; Yin et al., 2009). To further confirm the
position of (+)-ABA, a higher resolution structure of PYL3-
(+)-ABA using a N-terminal truncated PYL3 was obtained at
1.95 A˚ in the space group R32. The structure was identical to
the previous one except that an additional C-terminal tail in
Mol A was solved (Table 1). Surprisingly, a trans-homodimer is
first observed in crystal of PYL3-(+)-ABA (Figure 1C), which is
significantly different from cis-homodimer of apo-PYL3 (Fig-
ure 1A), other PYLs or PYLs-ABA complexes. When one PYL3
protomer in the trans-homodimer is superimposed with that in
the cis-homodimer, the other PYL3 protomer in the trans-homo-
dimer is rotated by almost 135 compared to that in the cis-ho-
modimer (Figure 1B).
To determine whether the trans-homodimer conformation
exists in other PYL3 complex, we also solved the structure of
PYL3 in complex with pyrabactin. The PYL3-pyrabactin complex
structure was also determined by molecular replacement and
was refined to 1.83 A˚ (Table 1). The pyrabactin position was veri-
fied by the clear electron density, and further confirmed by the
low thermal factors and Fo–Fc differential electron density map
(Figures S3B and S3C). There are two PYL3 protomers bound
to pyrabactin in each asymmetric unit (Figure S3C). This struc-
ture is similar to the PYL-(+)-ABA complex, in a trans-homodi-
meric conformation (Figure S3C).
Structural Features of the trans-Homodimers
In the above two complex structures, each lid L4 (Figure S2, also
known as gate [Melcher et al., 2009] or CL2 [Yin et al., 2009]) is
closed, whereas it is open in apo-PYL3 (Figure 2A). Compared
with the cis-homodimer (Figure 1A), L4, L5 (also known as latch
[Melcher et al., 2009] or CL3 [Yin et al., 2009]), L7, and the ABA
binding pocket (Figure 2A) in the trans-homodimer are more
exposed to the solvent (Figure 1C). Moreover, their temperature
factors are higher, implicating more flexibility in this region,
a partial interface for PP2Cs binding. Therefore, this feature
implies that the trans-homodimer conformation might promote
the binding of PYL3 and PP2C.
Here we elucidate the interactions that stabilize the trans-
homodimer. There are two hydrophobic network interaction
and several hydrogen bonds in the interface of the trans-homo-Structure 20dimer, mostly in loops L4, L2, and a4 (Figure 2B). Notably, two
hydrophobic networks (Figure 2B) are formed by Phe81,
Leu111, and Val192 in one PYL3 molecule, and by Val202
and Ile203 in the other. As expected, the triple mutant F81A
V202A I203A is monomer according to size exclusion chroma-
tography and analytical ultracentrifugation (Figures 3A and 5)
and retains ABA binding activity judged from its ability to
inhibit HAB1 (Figure 4). However, the inhibitory activity of
this mutant is lower than wild-type probably because F81A
reduces the binding of ABA (Figure 4). On the contrary, double
mutant V202A I203A enhances the inhibitory ability (Figure 4)
due to weaker hydrophobic interactions in the interface.
Other than the hydrophobic interactions in the interface, two
hydrogen bonds are formed between Asn199 in each protomer
(Figure 2B).
To clarify the details of the change in orientation of one PYL3
molecule relative to the other in the trans-homodimer, the angle
between the two a4 helices was calculated by MOLMOL (Koradi
et al., 1996). Upon ligand binding, one PYL3 protomer rotates by
135.5 when apo-PYL3 and ligand-bound PYL3 are superim-
posed. In contrast to PYL2, the two a4 helices and the two
PYL3 protomers approach closer after binding ligands (Fig-
ure 2B). However, the interface accessible surface area (Krissinel
and Henrick, 2007) decreases from 933.64 A˚2 to 868.09 A˚2 upon
binding to (+)-ABA. This observation suggests that the interac-
tion between the two PYL3 monomers become weaker upon
ligand binding. The trans-homodimer might easily dissociate
to the monomer and promote the formation of PYL3-PP2C
heterodimer.
Formation of the trans-Homodimer in Solution
It is controversial whether apo-PYLs or (+)-ABA-bound PYLs
exists as a monomer or dimer in solution. To understand how
two PYL3 protomers interact with each other, we employed
seven methods: gel filtration, crosslinking, disulfide bond engi-
neering, subunit exchange, mass spectrometry, SAXS, and
analytical ultracentrifugation, to confirm that the trans-homo-
dimer of PYL3 exists in solution and is not the result of a crystal
packing. We first evaluated the influence of ligands on the
oligomeric state of PYL3 by gel filtration on a calibrated
Superdex-200 HR10/30 column. Wild-type PYL3 was eluted at
15.9 ml, corresponding to a molecular weight of 44 kDa; in
the presence of (+)-ABA, it was eluted at 16.34ml (36 kDa) (Fig-
ure 3A). To determine whether the 16.34 ml peak corresponded, 780–790, May 9, 2012 ª2012 Elsevier Ltd All rights reserved 783
Figure 3. Formation of trans-Homodimer in Solution
(A) Elution profile of PYL3 or mutants with or without the addition of (+)-ABA by size-exclusion column chromatography.
(B) Crosslinking of PYL3 or mutants by EGS in different concentration.
(C) SDS-PAGE of PYL3 mutants under different reducing conditions. It shows that N180C T209C mutant forms a trans-dimer with the addition of ABA under
nonreducing conditions, whereas S195L block the formation of trans-dimer.
(D) Mass spectra of the N180C T209C mutant under different conditions.
See also Figures S4 and S5.
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Structures and Unique Mechanism of ABA Receptor PYL3to the monomer, we performed crosslinking followed by SDS-
PAGE to identify the crosslinked products. Using ethylene
glycol-bis(succinic acid N-hydroxysuccinimide ester) (EGS),
glutaraldehyde, or formaldehyde as crosslinking reagents, the
dimer bands increased with the concentration of crosslinking
reagents, both in the absence and in the presence of (+)-ABA.
Therefore, combination of the crosslinking results and the size
exclusion chromatography experiments imply that dimers are
the major species in solution (Figures 3B, S4A, and S4B). On
the contrary, the dimer band was not observed for the mono-
meric F81A V202A I203A mutant.
Moreover, analytical ultracentrifugation was used to assess
the states of apo- and ligand-bound PYL3 in solution. The sedi-
mentation velocity (SV) results indicate that 3.9% of apo-PYL3
exists as a monomer at 0.2 mM, whereas the proportion of
monomer increased to 18.2% in (+)-ABA bound PYL3 (Figure 5).
These data support that ligand-bound PYL3 mainly exists as
a dimer.
Although we have demonstrated that apo-PYL3 exists mainly
as a dimer in solution, it is not clear to which dimer conformation
the 16.34 ml peak observed by gel filtration corresponds. To
determine the predominate dimer species, we used disulfide
bond engineering to study the dimer conformation in solution.
Structural analysis shows that the two a4 helices are antiparallel
in the PYL3 trans-homodimer, whereas they are parallel in the
cis-homodimer. The a4 helices were scanned to find residues
that, when mutated to cysteine, could form a disulfide bond.
The distances between the Ca atoms of Asn180 and that of
Pro208 or Thr209 in two different protomers of the trans-homo-
dimer are 6.11 A˚ and 6.21 A˚, respectively, whereas both of them
are >35 A˚ in the cis-homodimer (Figure 2B). Considering that
the residues at the end of the C terminus are flexible and that
the Ca–Ca distance between cysteine residues in disulfide
bonds is usually 6.5 A˚, we speculated that a disulfide bond
would be formed between the above residues under appropriate
conditions. To test this hypothesis, Asn180, Pro208, or Thr209784 Structure 20, 780–790, May 9, 2012 ª2012 Elsevier Ltd All rightswere mutated to cysteine separately or in combination. Samples
of the purified proteins were subjected to SDS-PAGE under
reducing or nonreducing conditions. The N180C T209C double
mutant formed a dimer band only in the presence of (+)-ABA
under nonreducing conditions, not in the absence of ligand or
under reducing conditions (Figure 3C, i). The N180C P208C
T209C triple mutant had similar result (Figure S4C). On the
contrary, no dimer band was detected for WT, N180C, T209C
mutants under the same conditions, respectively. The ability to
form disulfide bonds implicates that the trans-homodimer is
formed in solution upon the addition of ligands, but not in the
absence of ligands. Interestingly, for an equal molar ratio mixture
of N180C mutant and T209C mutant (Figure 3C, iv), the dimer
band only appeared with the addition of the (+)-ABA under
nonreducing conditions, the same condition as the N180C
T209C double mutant. It shows that subunit exchange occurs
and a trans-heterodimer forms between the N180C mutant and
T209C mutant in the presence of (+)-ABA.
The states of apo- and ligand-bound PYL3 in solution were
further confirmed by mass spectrometry, widely used to deter-
mine protein disulfide bond (Barbirz et al., 2000; Gorman et al.,
2002). The free thiols in the intact protein were blocked by rapid
alkylation with iodoacetamide, followed by proteolytic cleavage
by trypsin overnight. From the diagrammatic representation
(Figure 6), the specific peptides formed by the proteolysis of
N180C T209C mutant in the presence of (+)-ABA were found
at m/z 4132.5 and 3871.0, whose disulfide bond were further
confirmed by reduction (Figure 3D). The two peptides were
reduced to cysteine-containing peptide at m/z 2411.1 with the
addition of DTT (Figure 3D). On the contrary, no similar peptides
were detected for the N180C T209C mutant without ligands. In
addition, the above two m/z values can not be formed for cis-
dimer or monomer, theoretically and experimentally. It clearly
shows that disulfide bond forms exclusively between residues
C180 and C209, and a trans-homodimer exists in the presence
of (+)-ABA.reserved
Figure 4. Inhibition of HAB1 by PYL3 Mutants in the Presence
of (+)-ABA
(A) The relative phosphatase activity of each reaction was normalized to that of
the reaction containing phosphopeptide substrate and HAB1 (100%). Each
reaction was repeated at least three times.
(B) GST pulldown experiments of PYL3mutants by GST-HAB1 in the presence
of (+)-ABA. GST-HAB1 and PYL3 are highlighted by arrows.
See also Figure S3.
Figure 5. Analytical Ultracentrifugation Data of PYL3 Mutants and
Complexes
c(s) distribution from sedimentation velocity analytical ultracentrifugation
experiments (SV) performed at 0.2mMprotein with or without 0.6mM (+)-ABA.
The change due to the adding of (+)-ABA observed in the c(s) distribution
confirms the presence of different kinds of dimers and monomer. PYL3 S195L
with (+)-ABA in the solution resembles PYL3 WT, overwhelmingly exists in cis-
dimer conformation. Nonetheless, the triple mutant F81A V202A I203A almost
exists as a monomer in the absence of (+)-ABA.
See also Figure S6.
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Structures and Unique Mechanism of ABA Receptor PYL3In addition to the aforementioned experiments, the diameter
and the shape of the particle observed by SAXS (Figure S5) are
consistent with the above results. In summary, these results
clearly show that PYL3 trans-homodimer mainly exists in the
solution with the addition of (+)-ABA.
S195L Keeps cis-Homodimer in the Presence of (+)-ABA
Another key question is why PYL3 is the only member of
subfamily III that adopts the trans-homodimer intermediate.
Structural comparison and analytical ultracentrifugation (Fig-
ure S6) experiments indicate that the interaction between two
PYL3 protomers in apo-PYL3 is weaker than in PYR1, PYL1, or
PYL2. Sequence alignment (Figure S2) shows that several amino
acids vary within this subfamily. In particular, Ser195 in PYL3
differs greatly from the corresponding leucine in PYR1, PYL1,
or PYL2.
Structural analysis shows that the two Ser195 residues in the
apo-PYL3 dimer are in the face-to-face conformation and that
the distance between the two Cb atoms is 4.59 A˚. On the
contrary, in the trans-homodimer of (+)-ABA-bound PYL3, the
two Ser195 residues are in the back-to-back conformation,
and the corresponding distance is 7.71 A˚. Therefore, mutation
of Ser195 to a hydrophobic residue should enhance the dimeric
interaction in apo-PYL3, but not in ligand-bound PYL3. To vali-
date this hypothesis, wemutated Ser195 to leucine. As expected
from the structural observations, the cis-homodimer state is
retained in the PYL3 S195L mutant upon addition of (+)-ABA
as determined by analytical ultracentrifugation (Figures 5, S6E,
and S6F). Moreover, the N180C S195L T209C triple mutant
does not form a dimer band in the presence of (+)-ABA under
nonreducing conditions, indicating the inability of this mutant
to form the trans-homodimer (Figure 3C, iii). The results indicate
that replacement of Ser195 with the hydrophobic leucine greatly
enhances the interactions in the cis-homodimer interface, and it
is difficult to break these interactions to produce trans-homo-
dimer upon the addition of ligands. Therefore, the single-site
mutation of serine to leucine accounts for the distinct mecha-
nism observed in PYL3.Structure 20Structure of the PYL3-(+)-ABA-HAB1 Complex
and the Inhibitory Mechanism of PP2C by PYL3
The major players in ABA signaling include a subclass of Mg2+-
and Mn2+-dependent serine-threonine PP2Cs. HAB1 plays
a major role and is a negative regulator of ABA signaling at an
early stage in the pathway. HAB1 is primarily expressed in meri-
stematic tissues, guard cells, embryos, and siliques. Therefore,
to study the role of ABA receptors on seed development, we
focused on studying the interaction between PYL3 and HAB1.
The PYL3-(+)-ABA-HAB1 complex structure contains one
PYL3 and one HAB1 (Figure 7A). The indole ring of W385 of
HAB1 inserts into the ABA binding pocket of PYL3. The structure
of PYL3-(+)-ABA in the PYL3-(+)-ABA-HAB1 complex is very
similar to PYL3-(+)-ABA complex with an rmsd of 0.7 A˚ calcu-
lated by the Dali server (Holm et al., 2008). However, there are
several unexpected conformational changes between them.
The most drastic changes are found in L4; in particular Pro112
moves closer to W385 of HAB1 and locks tightly into the pocket.
Moreover, the side chain of Arg140 becomes visible in the elec-
tron density of the PYL3-(+)-ABA-HAB1 complex and is involved
in binding to W385.
The overall structure of the PYL3-(+)-ABA-HAB1 complex is
similar to the PYL2-(+)-ABA-HAB1 complex (Melcher et al.,, 780–790, May 9, 2012 ª2012 Elsevier Ltd All rights reserved 785
Figure 6. Diagrammatic Representation of the Relationships of Ions Detected by MALDI-TOF-MS of Nonreduced and Reduced Samples
The N and C termini of each sequence are shown in single-letter code with their numerical locations in the protein sequence. The trypsin cleavage sites are
indicated by arrow. Them/z values correspond to the combinations of the ions from the reduced spectrum or theoretical values. An example of the computational
process would be a summation of the masses of V164-R186 (m/z 2616.9) plus S195-C209 (m/z 1518.7), less 2 u to form one interchain disulfide, to give the
nonreduced values ofm/z 4132.5, which loses two N-terminal residues VY to give a mass ofm/z 3871.0. In addition, the above twom/z values can not be formed
for cis-dimer or monomer theoretically. All measurements were made with external mass calibration.
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Structures and Unique Mechanism of ABA Receptor PYL32009), and the overall rmsd of the C-a atoms for PYL and HAB1
are 1.2 A˚ and 0.6 A˚, respectively. However, there are several
obvious differences in the binding interface. First, only one
Mn2+ is found in the active center of HAB1, whereas there are
three Mg2+ ions in the PYL2-(+)-ABA-HAB1 complex (Melcher
et al., 2009). Second, due to the smaller side chains of Ser106
and Val108 in PYL3 compared to that of PYL1, PYL2, and
PYR1 (Figures S2 and S3D), Leu111 moves more deeply to the
binding pocket in order to bind (+)-ABA, which will make the
binding of HAB1 weaker. Moreover, the electron density of
several side chains in the HAB1 active site is not visible, indi-
cating that the active site of HAB1 is more flexible than in other
PP2C structures. Third, in contrast to the PYL2-(+)-ABA-HAB1
complex structure, the conformation of residues E138 and
H139 in PYL3 (latch) is not changed. Finally, the hydrophilic
residue Ser195 greatly weakens the hydrophobic interaction
(Figure 7B) in the heterodimeric interface of PYL3-(+)-ABA-
HAB1, which is strengthened by Leu172 in PYL2 (corresponding
to Ser195 in PYL3) together with Phe81 and Tyr404 in HAB1.786 Structure 20, 780–790, May 9, 2012 ª2012 Elsevier Ltd All rightsHowever, the PYL3 S195L dimer is more difficult to disassociate
as mentioned above. Taking these two opposite effects into
account, S195L mutant slightly enhances the binding ability to
HAB1 (Figure S7A) and decrease the dissociation of dimeric
S195L mutant (Figures 4, S6E, S6F, and S7C). Therefore, these
differences can explain why the inhibitory activity of PYL3 is
lower than that of other members in subfamily III (Clade A), which
entirely contain a leucine at the corresponding site.
In the PYL3-(+)-ABA complex structure, the ABA binding
pocket is closed and exposed to solvent. This raises the question
of whether PP2C can directly bind to the ligand-bound PYL3
without the disassociation of the trans-homodimer. To test this
hypothesis, we engineered a disulfide bond within helices a4
that locks the protein in the trans-homodimer conformation.
The activity experiments show that PP2C is inhibited by 70%
in the N180C P208C T209C triple mutant (Figure S4D).
Compared to wild-type, the introduction of a disulfide bond will
secure the trans-homodimer conformation and block the forma-
tion of the PYL3-HAB1 heterodimer. We further confirmed thereserved
Figure 7. PYL3–ABA–HAB1 Complex Struc-
ture
(A) Overall structure of PYL3–ABA–HAB1
complex.
(B) The interface between PYL3 and HAB1 in the
PYL3–ABA–HAB1 complex. S195 is in the hydro-
phobic zone (magenta ellipse). W385 of HAB1
inserts the binding pocket. ABA, yellow; PYL3main
chain,blue;HAB1mainchain, red; side chain, cyan.
See also Figures S3 and S7.
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Structures and Unique Mechanism of ABA Receptor PYL3interaction using a yeast two-hybrid. The yeast two-hybrid
assays were performed using PYL3 or mutants as the bait and
HAB1 as the prey with and without (+)-ABA. We found that the
yeast grew faster for the PYL3 F81A V202A I203A mutant in
SDmedium lacking Leu, Trp, His, and Ade (SD-4) in the presence
of (+)-ABA (Figure S7A). These data show that monomeric PYL3
interacts with HAB1 more readily than the trans-homodimer. It is
consistent with the recent report that monomeric receptors have
a competitive advantage than dimeric receptors (Dupeux et al.,
2011). Therefore, the monomeric conformation is indispensable
for the inhibitory activity of PYL3.
Gate Closure and Nonproductive Binding
in the PYL3-Pyrabactin Complex
In the PYL3-pyrabactin complex, pyrabactin is stabilized in the
PYL3 pocket by hydrophobic interaction networks and several
hydrogen bonds. In Mol B of the PYL3-pyrabactin complex,
there are two sulfate ions. One sulfate ion binds in the binding
pocket and forms a salt bridge with Lys79 (Figure S3F). Another
sulfate ion is located between L4 and L5, forms several salt
bridges with Arg140 and makes loop L5 shift, which is the
distinct conformational change of Latch (L5) among all PYL
complex structures (Figure 2A). Compared with other PYL-pyra-
bactin complexes (Hao et al., 2010; Melcher et al., 2010;
Peterson et al., 2010; Yuan et al., 2010), the orientation of the
naphthalene and pyridine ring of pyrabactin in PYL3 is rotated
by 80 (Figures S8G and S8H). Moreover, the position of the
sulfonamide group moves to F81 and do not form a hydrogen
bond with Lys79, which is greatly different from other PYLs-
pyrabactin complexes. Last but not least, the conformation of
pyrabactin is the most compact compared to that of other
PYLs-pyrabactin complexes, which might decrease the binding
affinity to PYL3 because the contact surface between them is
reduced.
It was reported that PYL2–4 were the only pyrabactin-insensi-
tive PYLs and lid conformation was thought to be the key factor
(Melcher et al., 2010; Peterson et al., 2010; Yuan et al., 2010).
However, the lid L4 in the PYL3-pyrabactin complex is in the
closed conformation, which is completely different from that in
the PYL2 or PYL2 mutant pyrabactin complex (Figure 2A). TheseStructure 20, 780–790, May 9, 2012data raise the question of whether the
closed conformation of L4 in PYL3 can
bind to PP2C and inhibit the activity of
PP2C. To test this hypothesis, the inhibi-
tory activity of PYL3 on HAB1 was tested
with the ligands (+)-ABA and pyrabactin.
PYL3 can inhibit the phosphatase activityof HAB1 with an IC50 of 0.317 mM in the presence of (+)-ABA.
In the presence of pyrabactin, the IC50 increases to 627 mM
(Figure S8A). PYL3 only inhibited 44% of the phosphatase
activity of HAB1 in the presence of 500 mM pyrabactin. This
2,000-fold difference in selectivity of different ligands reflects
a change in the ability of PYL3 to bind to HAB1. Moreover,
isothermal titration calorimetry does not detect obvious binding
between PYL3 and pyrabactin due to extremely low binding
affinity, whereas the binding affinity (Kd) is 7.7 mM for (+)-ABA
(Figures S8B and S8C). Interestingly, V134I mutant increases
the inhibitory activity by 60% compared to wild-type (Fig-
ure S8D). This mutant might change the position and orientation
of pyrabactin in the binding pocket and enhance the inhibiting
activity.
Compared to the PYL3-(+)-ABA-HAB1 complex, lid L4 in the
PYL3-pyrabactin complex moves 1.63 A˚ toward a4 and tightly
closes the latch. In addition, due to the smaller side chains of
Ser106 and Val108 in PYL3 compared to that of PYL1, PYL2,
and PYR1 (Figures S2 and S3G), Leu111 binds to pyrabactin
tighter, which gives rise to lid L4 too close toward the pocket
compared to that in PYL1, PYL2, or PYR1. There is not enough
space between gate L4 and latch L5 for the insertion of Trp385
of HAB1. Therefore, the interaction between pyrabactin-bound
PYL3 and PP2C is seriously crippled (Figure S3I). Moreover,
residues Pro112, Leu141, Pro177, and Thr185 in the PYL3-
pyrabactin complex would clash with the side chain of Trp385
of HAB1 when superimposed with the PYL3-(+)-ABA-HAB1
complex. Therefore, the inhibitory ability of PYL3 on HAB1 is
weak when binding to pyrabactin. Taken together, pyrabactin
can work as an antagonist for PYL3 during the development
of seed.
DISCUSSION
In our study, apo-PYL3 cis-homodimer generates a distinct
conformational arrangement and becomes a trans-homodimer
upon ligand binding, which more easily dissociates into two
monomers. The monomeric PYL3 plays the role in physical inter-
action with PP2Cs and the trans-homodimer is an important
intermediate. The formation of the trans-homodimer in theª2012 Elsevier Ltd All rights reserved 787
Figure 8. The Mechanism for the Inhibition of PP2Cs by PYL3 with
Ligands
A characteristic change that one PYL3 in the apo-PYL3 cis-homodimer rotates
and forms a trans-homodimer occurs after apo-PYL3 recognizes and binds to
ligands. In turn, the trans-homodimer dissociates to monomer more easily and
binds to PP2C more conveniently than the cis-homodimer. Noteworthily, only
the appropriate gate closure can induce PP2C binding.
See also Figures S7 and S8 and Table S1.
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Structures and Unique Mechanism of ABA Receptor PYL3presence of ligands exposes a partial area of interface for
PP2Cs binding (Figures 1C and 7B). The newly exposed area
in trans-dimeric PYL3 is favorable for PP2C binding, which inge-
niously orchestrate the dissociation of homodimeric PYL3 to
monomer and the formation of heterodimer of PYL3-(+)-ABA-
PP2C. Combining our findings, we propose a specific mecha-
nism for PYL3 (Figure 8).
The PYL family, one of the star-related lipid-transfer (START)
protein families (Lytle et al., 2009), contains 14 members in
A. thaliana. Except for PYL13, which is inactive, all the PYLs
are ABA receptors (Fujii et al., 2009). From the phylogram of
the PYL/PYR/RCAR family, PYL3 is one of the most distinctive
proteins (Table S1a) and exists in limited species. Interestingly,
all the residues corresponding to S195 in PYL3 were not serine
among the found members of PYL/PYR/RCAR family in plants,
except in Arabidopsis lyrata. In addition, PYL3 is the only protein
among all the active members of the PYL/PYR family whose
isoelectric point (PI) is alkaline (Table S1b). Thus, the distinct
properties of PYL3 may justify the formation of the trans-homo-
dimer and the lower binding affinity to PP2C.
Analytical ultracentrifugation sedimentation equilibrium per-
formed on the apo-PYL3 and apo-PYL2 confirms that they
mostly exists as dimers with a dissociation constant (Kd) of
7.76 mM and 0.95 mM, respectively (Figures S6A and S6C). After
the addition of (+)-ABA, the Kd of PYL3 increased almost six
times, whereas the corresponding value for PYL2 is 3.32 mM
(Figures S6B and S6D). As expected, two protomers of the
mutant PYL3 S195L homodimerize more strongly with Kd of
1.16 mM and 7.23 nM with or without (+)-ABA, respectively
(Figures S6E and S6F). These results show that the PYL3
trans-homodimer more easily disassociates to the monomer
compared to the PYL3 mutant cis-homodimer and PYL2 cis-
homodimer in the present of (+)-ABA. The measured Kd value
of PYL3 trans-homodimer is a little higher than expected, but
there are several reasons to explain it. First, the above Kd had
to be measured at 4C due to the protein instability under
long duration of experiments at room temperature. However,
Arabidopsis grows at the room temperature. The Kd value is esti-788 Structure 20, 780–790, May 9, 2012 ª2012 Elsevier Ltd All rightsmated at the mM level from the sedimentation velocity analytical
ultracentrifugation at 20C (Figure 5). Second, there maybe are
some undiscovered partner components or special physiolog-
ical environment for PYL3 in vivo to lower the Kd value. In fact,
we do not get entangled with the measured Kd value in vitro as
unexpected. PYL3 can be excessively expressed and enriched
at some specific tissues and several stages, which makes it
possible that the local high concentration of PYL3 satisfies the
demand of Kd value as high asmeasured in vitro. The expression
level of PYL3 in the chalazal seed coat at the globular stage is
1,000 times higher than in the other tissues (e.g., the peripheral
endosperm). Therefore, it is reasonable to speculate that PYL3
trans-homodimer might exist in special tissues at particular
stages of development, such as in seed maturation. Of course,
the physiological conditions in vivo are so complicated and
changeable that PYL3 may exist as an equilibrium mixture of
trans-, cis-dimer, and monomer.
In addition, at a low proportion of PYL to HAB1 in the presence
of (+)-ABA, PYL3 had stronger inhibitory ability to HAB1,
whereas PYL2 lost nearly all inhibitory ability when the concen-
tration of PYL2 was less than half of HAB1 (Figure S7B). There-
fore, inhibition of HAB1 by PYL3 is kinetically favored at low
protein levels, whereas inhibition by PYR1, PYL1 or PYL2 is ther-
modynamically favored at high protein levels. These results
imply that the trans-homodimer may have important role at low
expression level.
Recently, two independent groups proposed that PYR/PYL/
RCAR proteins could be separated into two distinct subclasses
(Dupeux et al., 2011; Hao et al., 2011) according to the oligo-
meric state of their apo forms, including monomeric PYLs and
dimeric PYLs. Here, our structures support that PYL3 trans-
dimers occur under ligands such as (+)-ABA and pyrabactin,
which implies that the formation of trans-homodimer is a
common and true mechanism for PYL3. Therefore, our findings
extend the present classification of PYR/PYL/RCAR proteins.
According to the conformations of ligand-bound PYLs, there
are three PYR/PYL/RCAR subclasses, homodimeric PYLs such
as PYL1, PYL1, and PYL2, transdimeric PYL3, and monomeric
PYLs including PYL4–PYL6 and PYL8–PYL10. PYL7, PYL11,
and PYL12 are not identified thus far. Our classification can
deepen the understanding of the core question of PYLs recep-
tors: how do the 13 ABA-responsive PYLs, which share a high
degree of sequence identity, execute some distinct functions
in ABA signaling in vivo? The three PYR/PYL/RCAR subclasses
are corresponding to three different mechanisms of PYLs
response to ABA, which display different behaviors on percep-
tion of ABA concentration, binding ability to ABA, and efficiency
of inhibiting PP2C, etc. In different tissues and different physio-
logical conditions, plants may employ different ABA receptors
by different mechanisms to regulate different physiological
processes and response to different abiotic stresses.
In the study of ABA signaling, a central question is how this
small molecule is sensed. Productive and nonproductive modes
in ligand binding to PYL family members have been proposed
(Peterson et al., 2010) in which the gate closure responding to
ligand exclusively underlies the capacity of PYL inhibiting
PP2C (Melcher et al., 2009; Miyazono et al., 2009; Yin et al.,
2009). In the PYL3-pyrabactin complex, we discovered an unex-
pected, nonproductive binding mode. In this mode, the gatereserved
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Structures and Unique Mechanism of ABA Receptor PYL3closes too tightly to bind to PP2C. The PYL3-pyrabactin struc-
ture with an excessive closure of L4 is incompatible for interac-
tion with HAB1, and thus inhibits PP2C very weakly. Therefore,
only the appropriate gate closure can induce PP2C binding. It
was found that pyrabactin was an agonist for PYR1 and PYL1
by gate closure, an antagonist for PYL2 by gate open (Hao
et al., 2010; Melcher et al., 2010; Peterson et al., 2010; Yuan
et al., 2010). However, our structural analysis and biochemical
data show that pyrabactin works as an antagonist for PYL3 using
different mechanism. These data will provide unique evidence
for designing small chemical compounds for improving plant
performance in the future.
Our biochemical, mutational, and structural analyses also
reveal how PYL3 differs from other PYLs upon ABA binding. A
distinct molecular mechanism linking PYL3 to transcriptional
regulation (Figure 8) was proposed here. Taken together, these
results reveal a distinct insight for substrate selectivity and
provide an approach for the design of special agonists and
antagonists. These data and structural analyses also suggest
that ligand-bound PYL3 differs greatly from apo-PYL3 and other
PYLs. To determine whether this intermediate exists in other PYL
proteins, more structural and functional data in vivo are needed.
EXPERIMENTAL PROCEDURES
Crystallization
Crystallizations were performed at room temperature by hanging-drop vapor
diffusion method. Apo-PYL3 crystal was grown at room temperature in the
hanging drop containing 1.0 ml purified PYL3 (residues 1–209) protein at
20 mg/ml and 1.0 ml of reservoir solution that included 2.3 M (NH)2SO4,
0.1 M BTP pH 8.25. To get the PYL3-S-(+)-ABA complex crystals, a homoge-
neous and stable PYL3-(+)-ABA complex in solution should be first formed.
S-(+)-ABA (hereafter referred to as (+)-ABA) was mixed with PYL3 (residues
25–209) at 5:1 ratios and stayed on ice for 3 hr. The mixtures were
applied to gel exclusion chromatography and the fractions corresponding to
the homogeneous complexes were concentrated for crystallization. The
complex PYL3-(+)ABA crystal appeared in the hanging drop containing 1 ml
of purified protein at 18 mg/ml mixed with 1 ml of well solution that contained
1.6 M (NH)2SO4, 0.1 M HEPES pH 7.6. To obtain PYL3-pyrabactin complex
crystal, the fragment of PYL3 (residues 21–209) was found to be better for
complex crystallization. Pyrabactin was mixed with PYL3 at 10:1 ratios and
stayed on ice overnight. PYL3-pyrabactin complex crystals were grown in
the well buffer containing 1.7 M (NH)2SO4, 0.1 M NaCaCodylate pH 6.3,
0.2 M NaCl. The crystals were transferred into the well solution containing
30% glycerol as cryo-protectant solution and flash cooled in liquid nitrogen
before collecting data.
To form a homogeneous and stable HAB1-PYL3-(+)-ABA ternary complex,
PYL3 (full length) and HAB1 (residues 169–511) was overexpressed and puri-
fied respectively. Then (+)-ABA was mixed with HAB1:PYL3 at 5:1:1 ratios in
the presence of 5 mM MgCl2 on ice overnight. The mixtures were applied to
gel exclusion chromatography and the fractions corresponding to the homo-
geneous complex were concentrated to 10 mg/ml. The HAB1-PYL3-(+)-ABA
ternary complex crystal appeared in the hanging drop containing 1 ml of puri-
fied proteins mixed with 1 ml of well solution that contained 28% PEG3350,
0.2 M MgCl2, 0.1 M Tris-HCl pH 7.8. The crystal was transferred into the
well solution containing 20% glycerol as cryo-protectant solution and flash
cooled in liquid nitrogen before data collection.
Data Collection and Processing
To solve the PYL3 structures, the apo-PYL3 crystal is soaked in the crystalli-
zation well solution with 1 mM K2PtCl6 overnight. A high-resolution data set
(2.5 A˚) of native PYL3 and K2PtCl6 soaked PYL3 were collected at 100 K for
a single crystal on beam line NE3A at the Photon Factory (KEK). The data of
the complex structure of PYL3-(+)-ABA (space group I 212121), and HAB1-Structure 20PYL3-(+)-ABA were collected on Spring-8 beamline BL41XU. The data of
the complex structure of PYL3-(+)-ABA (space group R32) and PYL3-pyrabac-
tin were collected at beamline 1W2B at the Beijing Synchrotron Radiation
Facility. All the data were integrated and scaled with the HKL2000 suite of
programs (Otwinowski andMinor, 1997). Data collection statistics are summa-
rized in Table 1.
MALDI-TOF Assays
Detection by MALDI-TOF mass spectrometry (Autoflex II TOF/TOF, Bruker
Daltonics) was carried out as previously described (Yu et al., 2010). For the
reduced state, a final concentration of 5 mM DTT was added to reduce the
existing disulfide bond. The free thiols in the intact protein were blocked by
rapid alkylation with iodoacetamide for 2 hr, followed by proteolytic cleavage
by trypsin overnight at 37C.
Apo-PYL3 cis-Homodimer Converted into PYL3-(+)-ABA
trans-Homodimer Verified by Introducing Disulphide
According to the remarkable difference of crystal structure between apo-PYL3
and PYL3-(+)-ABA, four mutants N180C, N180C T209C, N180C P208C
T209C, and N180C S195L T209C ware engineered into pET-28a vector. After
an additional purification by Ni-charged resin (BIO-RAD) and followed by size
exclude chromatography, purifiedHis tagged PYL3mutants were subjected to
disulphide formation. Sixty micrograms of His-tagged PYL3 was mixed with or
without (+)-ABA for1 hr, then redox condition was applied by different ratio of
oxidized glutathione (GSSH) and reduced glutathione (GSH) overnight in 4C.
For the subunit exchange experiment, an equal molar of N180C and T209C
mutants were mixed. The protein samples were visualized by SDS-PAGE
with or without 1% bME followed by Coomassie blue staining.
Details of protein preparation, phosphatase activity assay, GST-mediated
pulldown assay, crosslinking gel assay, gel exclusion chromatography, small
angle X-ray scattering experiments, isothermal titration calorimetry (ITC)
assays, analytical ultracentrifugation, experimental phasing, and yeast two-
hybrid analysis are described in Supplemental Experimental Procedures.
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